These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8148218)

  • 1. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
    Lyons D; Webster J; Fowler G; Petrie JC
    Br J Clin Pharmacol; 1994 Jan; 37(1):59-62. PubMed ID: 8148218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
    Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
    Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.
    Superko HR; Greenland P; Manchester RA; Andreadis NA; Schectman G; West NH; Hunninghake D; Haskell WL; Probstfield JL
    Am J Cardiol; 1992 Jul; 70(2):135-40. PubMed ID: 1626496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia.
    Spence JD; Huff MW; Heidenheim P; Viswanatha A; Munoz C; Lindsay R; Wolfe B; Mills D
    Ann Intern Med; 1995 Oct; 123(7):493-9. PubMed ID: 7661492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
    Davis TA; Anderson EC; Ginsburg AV; Goldberg AP
    J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia.
    Tonstad S; Ose L; Gørbitz C; Harrison EM; de Koning Gans HJ
    Scand J Clin Lab Invest; 1993 Aug; 53(5):457-63. PubMed ID: 8210967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
    N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
    Dujovne CA; Krehbiel P; Chernoff SB
    Am J Cardiol; 1986 Jun; 57(16):36H-42H. PubMed ID: 3524176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
    Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
    Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
    Vega GL; Grundy SM
    JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of colestipol in the treatment of hyperthyroidism.
    Hagag P; Nissenbaum H; Weiss M
    J Endocrinol Invest; 1998 Dec; 21(11):725-31. PubMed ID: 9972670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of encapsulated, low-dose colestipol in patients with hyperlipidemia.
    Linet OI; Grzegorczyk CR; Demke DM
    J Clin Pharmacol; 1988 Sep; 28(9):804-6. PubMed ID: 3230147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of high-density lipoproteins in drug lipid-lowering treatment].
    Mordasini R; Riesen W; Oster P; Riva G
    Schweiz Med Wochenschr; 1982 Jan; 112(3):95-8. PubMed ID: 7058319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.